Frontiers of Hormone Research
Overview
Frontiers of Hormone Research is a scientific journal, published since 1972 in English. The journal's country of origin is Switzerland.
Details
Details
Abbr.
Front Horm Res
Start
1972
End
Continuing
Frequency
Annual
p-ISSN
0301-3073
e-ISSN
1662-3762
Country
Switzerland
Language
English
Metrics
Metrics
h-index / Ranks: 7992
45
SJR / Ranks: 8393
537
CiteScore / Ranks: 3145
6.70
Recent Articles
1.
Almeida A, Ramaglia A, Severino M, Tortora D, Di Iorgi N, Rossi A
Front Horm Res
. 2024 Nov;
55:1-17.
PMID: 39586295
Growth hormone deficiency can be congenital or acquired. While acquired cases are related to organic causes that affect the hypothalamic-pituitary axis, structural abnormalities may or may not be detected in...
2.
Toni R, Barbaro F, Di Conza G, Elviri L, Mosca S, Caravelli S, et al.
Front Horm Res
. 2024 Nov;
55:98-118.
PMID: 39586281
The term 'fugitive acromegaly' was introduced by the neurosurgeons Bailey and Cushing in 1928 to describe subjects manifesting signs and symptoms of somatotroph hyperfunction with pituitary insufficiency. Currently, it identifies...
3.
Hong C, Gerstl J, Maniar K, Kilgallon J, Min L, Onnela J, et al.
Front Horm Res
. 2024 Nov;
55():215-225.
PMID: 39586278
Methods to assess quality of life and recovery after endoscopic endonasal surgery (EES) for sellar lesions are limited and often biased by subjective patient-reported assessments. Objective in-situ assessments are lacking....
4.
Aversa L, Sibilla M, Prencipe N, Gasco V, Ghigo E, Grottoli S
Front Horm Res
. 2024 Nov;
55:182-200.
PMID: 39586277
Somatostatin and its analogs have been for years a mainstay treatment for a variety of hypersecretory conditions and neoplasms of the endocrine system. This chapter summarizes their pharmacological properties, their...
5.
Cotta O, Bonsangue M, Cannavo S
Front Horm Res
. 2024 Nov;
55:56-67.
PMID: 39586272
The syndrome of growth hormone deficiency (GHD) in adulthood is characterized by adverse changes in body composition, reduced exercise capacity and quality of life, alterations in cardiovascular function as well...
6.
Daly A, Petrossians P, Beckers A
Front Horm Res
. 2024 Nov;
55:82-97.
PMID: 39586271
Pituitary acrogigantism is a very rare disease that is caused by chronic growth hormone (GH) axis excess that begins during childhood and adolescence. As such, it represents one of the...
7.
Zoli M, Carretta A, Magnani M, Guaraldi F, Rustici A, Sollini G, et al.
Front Horm Res
. 2024 Nov;
55:159-181.
PMID: 39586267
Introduction: Endoscopic endonasal approach (EEA) plays a central role in the treatment of GH-secreting pituitary adenomas (PAs)/pituitary neuroendocrine tumors (PitNETs), allowing to treat not only micro- or regular macro- PAs/PitNEts,...
8.
Amodeo M, Morgante C, Pampanini V, Deodati A, Cianfarani S
Front Horm Res
. 2024 Nov;
55:18-28.
PMID: 39586265
The past century witnessed the evolution of growth hormone (GH) treatment from pituitary-derived GH, available for treatment of selected cases of GH deficiency (GHD), to recombinant human GH (rhGH), currently...
9.
Guaraldi F, Di Sciascio L, Shwaish T, Zoli M, Mazzatenta D, Asioli S
Front Horm Res
. 2024 Nov;
55:119-132.
PMID: 39586264
Acromegaly is a rare disorder characterized by chronic hypersecretion of growth hormone (GH) and, consequently, of its mediator, insulin-like growth factor 1 (IGF-1), due in >95% of the cases to...
10.
Logoluso F
Front Horm Res
. 2024 Nov;
55:133-142.
PMID: 39586263
Acromegaly is a chronic systemic disease, with a long clinical history, requiring a holistic approach to fully understand patient issues: the longer the time of disease activity, the greater will...